Citations

Showing 10 of 108094 citations.

Noninvasive neuromodulation in essential tremor demonstrates relief in a sham‐controlled pilot trial
Lin, Peter , Ross, Erika K. , Chidester, Paula, Rosenbluth, Kathryn H. , Hamner, Samuel R. , Wong, Serena H., Delp, Scott L. , Ross, Erika K. , Sanger, Terence D. , Hallett, Mark

Mayo Clinic

Movement Disorders | April 17, 2018 | Volume: 33 | Issue: 7 | Pages: 1182-1183

10.1002/mds.27350 | PMID 29663525 Get It

The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance
Hersh, David S. , Harder, Bryan , Roos, Alison , Peng, Sen, Heath, Jonathan E., Legesse, Teklu, Kim, Anthony J. , Woodworth, Graeme F., Tran, Nhan L. , Winkles, Jeffrey A. , Harder, Bryan G., Winkles, Jeffrey A , Tran, Nhan L , Woodworth, Graeme F

Mayo Clinic

Neuro-Oncology | April 17, 2018 | Volume: 20 | Issue: 10 | Pages: 1321-1330

10.1093/neuonc/noy063 | PMID 29897522 Get It

Anatomic total shoulder arthroplasty with posterior capsular plication versus reverse shoulder arthroplasty in patients with biconcave glenoids: A matched cohort study
Wanderman, Nathan , Assenmacher, Andrew T. , Sperling, John W. , Cofield, Robert H. , Alentorn-Geli, Eduard, Wanderman, Nathan R, Assenmacher, Andrew T , Sanchez-Sotelo, Joaquin, Alentorn‐Geli, Eduard , Sánchez‐Sotelo, Joaquín

Mayo Clinic

Journal of Orthopaedic Surgery | April 17, 2018 | Volume: 26 | Issue: 2 | Pages: No page available

10.1177/2309499018768570 | PMID 29661111 Get It

Purpose: To compare the outcomes of total shoulder arthroplasty (TSA) with posterior capsule plication (PCP) and reverse shoulder arthroplasty (RSA) in patients with primary osteoarthritis, posterior subluxation, and bone loss (Walch B2). Patients and methods: All shoulders undergoing anatomic TSA with PCP were retrospectively identified (group 1, G1) and compared to shoulders undergoing RSA (group 2, G2) for Walch B2 osteoarthritis. There were 15 patients in G1 (mean (SD) age and follow-up of 70.5 (7.5) years and 42.8 (18.4) months, respectively) and 16 patients in G2 (mean (SD) age and follow-up of 72.6 (5.4) years and 35.1 (14.2) months, respectively). Results: Both groups had substantial improvements in pain and function. In G1, results were excellent in 80% and satisfactory in 20%, compared to 81% and 6% in G2, respectively ( p = 0.2). The mean (SD) American Shoulder and Elbow Surgeons score was 91.2 (6.7) and 80.3 (14.3) in G1 and G2, respectively ( p = 0.08). The mean Simple Shoulder Test score was 10.6 in G1 and 8.5 in G2 ( p = 0.01). There were no reoperations in either group, but G1 had seven postoperative complications. Conclusions: The outcomes of TSA with PCP are comparable to RSA in patients with osteoarthritis and biconcave glenoids. However, TSA leads to more complications while RSA leads to lower functional outcomes.
Adiposity, Body Composition and Ventricular–Arterial Stiffness in the Elderly: The Atherosclerosis Risk in Communities Study
Fernandes-Silva, Miguel Morita , Shah, Amil M. , Claggett, Brian , Cheng, Susan , Tanaka, Hirofumi , Silvestre, Odílson Marcos , Nadruz, Wilson , Borlaug, Barry A. , Solomon, Scott D. , Borlaug, Barry A , Solomon, Scott David , Shah, Amil

Mayo Clinic

European Journal of Heart Failure | April 17, 2018 | Volume: 20 | Issue: 8 | Pages: 1191-1201

10.1002/ejhf.1188 | PMID 29663586 Get It

Abstract Aim Weight gain appears to accelerate age-related ventricular–arterial stiffening, which has been implicated in the development of heart failure (HF), but it is unclear whether body fat accumulation underpins this association. We evaluated the relationship of adiposity, using measures of body composition, with ventricular–arterial stiffness among the elderly in the community. Methods and results Adiposity was accessed through body mass index (BMI), waist circumference, and body fat percentage. We studied the association of these measures with carotid–femoral pulse wave velocity (cfPWV), arterial elastance index (EaI), left ventricular (LV) end-systolic elastance index (EesI) and LV end-diastolic elastance index (EedI) in 5520 community-based, elderly Atherosclerosis Risk in Communities (ARIC) Study participants, who underwent echocardiography between 2011 and 2013. BMI and waist circumference were directly associated with EaI, EedI and EesI even after adjusting for age, sex, race, hypertension, diabetes mellitus, heart rate, prevalent coronary heart disease and HF. After further adjustment for BMI, body fat percentage demonstrated significant independent linear relationships with EaI [standardized beta coefficient (β)=0.17, P<0.001], EesI (β=0.08, P=0.003) and EedI (β=0.20, P<0.001), and significant non-linear relationships with cfPWV (P=0.033). Conclusion In this biracial community-based cohort, increased adiposity was associated with increased ventricular–arterial stiffness among the elderly and suggests a potential mechanism by which obesity might contribute to the development of HF.
TDP‐43 pathology in multiple system atrophy: colocalization of TDP‐43 and α‐synuclein in glial cytoplasmic inclusions
Koga, Shunsuke , Lin, W.‐L., Walton, Ronald L., Ross, Owen A. , Koga, Shunsuke , Ross, Owen A , Lin, W.‐L., Dickson, Dennis W.

Mayo Clinic

Neuropathology and Applied Neurobiology | April 16, 2018 | Volume: 44 | Issue: 7 | Pages: 707-721

10.1111/nan.12485 | PMID 29660838 Get It

AimsThis study aimed to assess clinicopathologic features of transactive response DNA‐binding protein of 43 kDa (TDP‐43) pathology and its risk factors in multiple system atrophy (MSA).MethodsParaffin‐embedded sections of the amygdala and basal forebrain from 186 autopsy‐confirmed MSA cases were screened with immunohistochemistry for phospho‐TDP‐43. In cases having TDP‐43 pathology, additional brain regions were assessed. Immunohistochemical and immunofluorescence double‐staining and immunogold electron microscopy (IEM) were performed to evaluate colocalization of TDP‐43 and α‐synuclein. Genetic risk factors for TDP‐43 pathology were also analysed.ResultsImmunohistochemistry showed various morphologies of TDP‐43 pathology in 13 cases (7%), such as subpial astrocytic inclusions, neuronal inclusions, dystrophic neurites, perivascular inclusions and glial cytoplasmic inclusions (GCIs). Multivariable logistic regression models revealed that only advanced age, but not concurrent Alzheimer's disease, argyrophilic grain disease or hippocampal sclerosis, was an independent risk factor for TDP‐43 pathology in MSA (OR: 1.11, 95% CI: 1.04–1.19, P = 0.002). TDP‐43 pathology was restricted to the amygdala in eight cases and extended to the hippocampus in two cases. The remaining three cases had widespread TDP‐43 pathology. Immunohistochemical and immunofluorescence double‐staining and IEM revealed colocalization of α‐synuclein and TDP‐43 in GCIs with granule‐coated filaments. Pilot genetic studies failed to show associations between risk variants of TMEM106B or GRN and TDP‐43 pathology.ConclusionsTDP‐43 pathology is rare in MSA and occurs mainly in the medial temporal lobe. Advanced age is a risk factor for TDP‐43 pathology in MSA. Colocalization of TDP‐43 and α‐synuclein in GCIs suggests possible direct interaction between the two molecules.
Metabolic coupling of axons and glial cells
Benarroch, Eduardo E. , Correale, Jorge, Ysrraelit, María C, Correale, Jorge Daniel , Ysrraelit, María Célica

Mayo Clinic

Neurology | April 16, 2018 | Volume: 90 | Issue: 16 | Pages: 737-744

10.1212/wnl.0000000000005339 | PMID 29661892 Get It

Clinical Reasoning: A 56-year-old woman with acute vertigo and diplopia
Sharma, Rishi , Chakraborty, Tia , Pureza, Vincent , Pagani-Estevez, Gabriel L., Buadi, Francis K. , Pureza, Vincent S, Beam, Elena , Pagani-Estévez, Gabriel L., Flanagan, Eoin P.

Mayo Clinic

Neurology | April 16, 2018 | Volume: 90 | Issue: 16 | Pages: 748-752

10.1212/wnl.0000000000005337 | PMID 29661894 Get It

Time to plateau as a predictor of survival in newly diagnosed multiple myeloma
Mellors, Patrick , Binder, Moritz , Lacy, Martha Q. , Hayman, Suzanne R. , Kapoor, Prashant , Gonsalves, Wilson I. , Hwa, Yi L. , Fonder, Amie , Hobbs, Miriam, Kourelis, Taxiarchis , Warsame, Rahma , Zeldenrust, Steven R., Lust, John A., Kyle, Robert A. , Kumar, Shaji , Mellors, Patrick W , Buadi, Francis K. , Gonsalves, Wilson , Warsame, Rahma , Leung, Nelson , Go, Ronald S , Binder, Moritz , Gertz, Morie A. , Dispenzieri, Angela , Leung, Nelson , Go, Ronald S. , Rajkumar, S. Vincent

Mayo Clinic

American Journal of Hematology | April 16, 2018 | Volume: 93 | Issue: 7 | Pages: 889-894

10.1002/ajh.25113 | PMID 29659048 Get It

AbstractResponse rates in newly diagnosed multiple myeloma have improved dramatically with the introduction of highly effective novel therapies. However, survival in patients achieving optimal responses to initial treatment can vary significantly, and new prognostic indicators are required to improve risk stratification. We investigated the relationship between time to plateau (TPlat) and survival in 1099 newly diagnosed patients treated with novel agents at our institution from 2005 to 2015.TPlatwas defined as time from initiation of first‐line therapy to best response to first‐line therapy. The medianTPlatwas 4.9 months (0.7‐58.6) and plateau duration was 1.8 years (0.2‐11.0). Patients who required > 120 days to achieve a plateau had longer modified overall survival (mOS) and progression free survival (mPFS) calculated from a landmark of best response (P < .001 for both comparisons). Statistically significant improvement in mOS was retained in subgroup analysis based on age and whether patients received upfront autologous hematopoietic stem cell transplantation (ASCT) (P < .001 for all comparisons). Our results suggest that patients who respond more gradually to initial therapy (TPlat > 120 days) experience longer survival compared to more rapid responders. Patients with a prolongedTPlatcould represent an “ongoing responder” phenotype that portends a survival advantage independent of treatment with upfront ASCT, depth of response, and biologic markers such as ISS stage and cytogenetic risk.